POMC and nephrotic syndrome: In contrast, a recent paediatric RCT – The ATLANTIS randomized trial for adrenocorticotropic hormone for childhood nephrotic syndrome – has reported that twice-weekly administration of ACTH (80 U/1.73m2) was not effective in preventing relapses in children with FRNS or SDNS [132].